Pfizer has been slapped with a $107 million fine in Britain for a price increase of its epilepsy drug. The fine was levied by Britain’s Competition and Markets Authority.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2016-12-07 05:38:002016-12-07 13:08:19Pfizer Fined a Record $107 Million for Ramping Up Epilepsy Drug Price
